Huadong Medicine Co., Ltd
000963
Pozycja w akcjach
#2704
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
Cena akcji
$3.89
Kapitalizacja rynkowa
$6.83B
Zmiana (1 dzień)
-2.22%
Zmiana (1 rok)
-30.58%
Kraj
CN
Handel Huadong Medicine Co., Ltd (000963)
Kategoria
Healthcare
EPS dla Huadong Medicine Co., Ltd (000963)
EPS na dzień June 2026 TTM: $0.30
Według najnowszych raportów finansowych i ceny akcji firmy Huadong Medicine Co., Ltd, obecny EPS (TTM) wynosi $0.30. Na koniec roku 2024 firma miała EPS w wysokości $0.28, wzrost w porównaniu do do EPS z roku 2023, który wynosił $0.23.
Historia EPS dla Huadong Medicine Co., Ltd od 2001 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $0.30 | 5.36% |
| 2025 | $0.28 | 1.20% |
| 2024 | $0.28 | 20.31% |
| 2023 | $0.23 | 10.42% |
| 2022 | $0.21 | -0.19% |
| 2021 | $0.21 | -15.74% |
| 2020 | $0.25 | 6.62% |
| 2019 | $0.23 | 23.31% |
| 2018 | $0.19 | 19.58% |
| 2017 | $0.16 | 31.21% |
| 2016 | $0.12 | 10.85% |
| 2015 | $0.11 | 39.10% |
| 2014 | $0.08 | 27.05% |
| 2013 | $0.06 | 26.82% |
| 2012 | $0.05 | 26.25% |
| 2011 | $0.04 | 25.74% |
| 2010 | $0.03 | -13.92% |
| 2009 | $0.04 | 118.63% |
| 2008 | $0.02 | 6.62% |
| 2007 | $0.02 | 69.66% |
| 2006 | $0.01 | 45.90% |
| 2005 | $0.01 | 221.05% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | -34.48% |
| 2002 | 0.00 | -12.12% |
| 2001 | 0.00 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| $0.72 | 145.12% |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 88.58% |
IN
|
